€4.56
0.89% day before yesterday
Xetra, Sep 06, 05:36 pm CET
ISIN
DE000A0BL849
Symbol
V3V
Index
Sector
Industry

Vita 34 Stock price

€4.56
+0.08 1.79% 1M
+0.00 0.00% 6M
-0.68 12.98% YTD
-0.76 14.29% 1Y
-11.29 71.23% 3Y
-7.04 60.69% 5Y
+0.76 20.00% 10Y
Xetra, Closing price Fri, Sep 06 2024
+0.04 0.89%
ISIN
DE000A0BL849
Symbol
V3V
Index
Sector
Industry

Key metrics

Market capitalization €79.49m
Enterprise Value €81.85m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 9.89
EV/Sales (TTM) EV/Sales 1.04
P/S ratio (TTM) P/S ratio 1.01
P/B ratio (TTM) P/B ratio 3.44
Revenue growth (TTM) Revenue growth 7.83%
Revenue (TTM) Revenue €78.82m
EBIT (operating result TTM) EBIT €-3.25m
Free Cash Flow (TTM) Free Cash Flow €8.28m
Cash position €14.44m
EPS (TTM) EPS €-0.02
P/E forward 45.60
P/S forward 0.98
EV/Sales forward 1.01
Show more

Is Vita 34 a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Vita 34 Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Vita 34:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Vita 34:

Buy
100%

Financial data from Vita 34

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
79 79
8% 8%
100%
- Direct Costs 49 49
25% 25%
62%
30 30
287% 287%
38%
- Selling and Administrative Expenses 24 24
2% 2%
31%
- Research and Development Expense - -
-
-
5.50 5.50
134% 134%
7%
- Depreciation and Amortization 8.75 8.75
2% 2%
11%
EBIT (Operating Income) EBIT -3.25 -3.25
87% 87%
-4%
Net Profit -0.13 -0.13
99% 99%
0%

In millions EUR.

Don't miss a Thing! We will send you all news about Vita 34 directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Vita 34 Stock News

EQS
3 days ago
Einstufung von Montega AG zu Vita 34 AG
EQS
9 days ago
Die Umsatzerlöse stiegen im ersten Halbjahr um 4,9 Prozent auf 38,0 Mio. Euro (H1 2023: 36,3 Mio. EUR), wobei allein im zweiten Quartal ein Wachstum von 6,0 Prozent erzielt wurde. Die Nettosumme in Rechnung gestellter Leistungen im Endkundengeschäft (B2C) lag mit 35,9 Mio. EUR um 13,1 Prozent übe...
EQS
29 days ago
Leipzig, 9. August 2024 – Die Vita 34 AG gab am 27. September 2023 bekannt, dass ihre Tochtergesellschaften FamiCordTx S.A. ("FamiCordTx") und Polski Bank Komórek Macierzystych sp. z o.o. ("PBKM") eine Klage gegen ein US-amerikanisches Biotechnologieunternehmen ("Lizenzgeber") eingereicht haben, ...
More Vita 34 News

Company Profile

Vita 34 AG engages in the collection and storage of umbilical cord blood and stem cells. The firm collects, processes, and stores stem cells from umbilical cord blood and tissue, and develops cell therapy processes. The company was founded by Eberhard F. Lampeter on April 28, 1997 and is headquartered in Leipzig, Germany.

Head office Germany
CEO Jakub Baran
Employees 745
Founded 1997
Website www.vita34.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today